Endocrinology

Offspring born to mothers with any diabetes diagnosis during pregnancy were more likely to develop any psychiatric disorder or specific disorders, compared to their unexposed peers.

The first iteration of Crisis Point addresses the obesity crisis in the United States and beyond, with expert interviews and discussion.

A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.

An analysis of 5 years of follow-up data from more than 90k Medicare beneficiaries suggests undergoing sleeve gastrectomy was associated with lower risk of mortality, complications, and reintervention, but an increased risk of surgical revision compared to gastric bypass.

A comparison of data from expansion states and nonexpansion states suggests access to bariatric surgery has increased since the ACA Medicaid expansion, but the increase in access has been limited mainly to non-Hispanic White patients.

Hospitalization rates from the baseline to Cycle 3 decreased 19% from 0.52/person/year to 0.43/person/year

Dr. Ponder continued his discussion on technology use in pediatric T1D care, focusing on a multidisciplinary care angle and different concepts in treatment.

Dr. Ponder discusses the importance of both clinician and patient learning about new diabetic technologies, focusing on their utility and limitations in the care process.

Dr. Buchholz discussed the idea of screening and intervening in patients with food insecurity, both in the clinical setting and in the community.

Dr. Buchholz discusses who is most at-risk of food insecurity and comorbid factors that stem from lack of access to healthy food.

Data show 5 of 20 patients with history of MBS in the study experienced the primary composite outcome of IMV and/or death by day 7.

Diabetes progression included greater likelihood of insulin treatment initiation, hyperglycemia, glycemic complications, and glucose-lowering prescriptions.

Episode 3 of Crisis Point examines the regional differences in obesity, from issues with nutrition and food insecurity to the use of the phrase "food desert".

New data presented at EASD 2021 suggests patients with metabolically healthy obesity were at a 34% greater risk of developing new-onset heart failure and a 33% greater risk of new-onset AF than counterparts of healthy weight and no metabolic abnormalities.

An analysis of NHANES data presented at EASD 2021 details the effects of returning to a healthy weight among patients with obesity compared to those currently with obesity and those who always maintained a healthy weight.

In patients with T2D without prior CVD, chronic kidney disease was the single risk factor associated with highest risk of MACE.

September's endocrine month in review features news related to diabetes, polycystic ovary syndrome, warnings from the FDA and FTC, and a column from Dr. Paul Thompson.

Sotagliflozin reduced HbA1c by 0.42% and heart failure by 32% in comparison to placebo.

Episode 2 of HCPLive Crisis Point tackles the clinical aspects and potential burdens clinicians face in the pursuit of obesity care.

A meta-analysis builds upon previous research and provides new insight into the total costs of diagnosis and treating PCOS as well as the costs of treating PCOS-related comorbidities.

A Cleveland Clinic trial assessing the effects of 3 healthy eating patterns in children with overweight or obesity details the improvements in cardiovascular risk factors seen with adherence to a healthy eating pattern.

The risk of TB was 48% higher in patients with diabetes compared to those without diabetes, while participants with IFG showed no increased risk of TB incidence.

Released on September 20, the latest scientific statement from the AHA outlines potential strategies, including lifestyle modifications, pharmacologic therapies, and weight loss surgery, for the prevention and treatment of obesity hypertension.

A total of 269 participants were considered potentially overtreated, while 109 participants were appropriately on target, and 56 participants potentially undertreated.

Erica P. Gunderson, PhD, MS, MPH, offers perspective on the current state of gestational diabetes management as well as avenues for improving current diagnostic and management standards.